Anatara Lifesciences (Australia) Insiders

Anatara Lifesciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.7607) % which means that it has lost $0.7607 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4732) %, meaning that it generated substantial loss on money invested by shareholders. Anatara Lifesciences' management efficiency ratios could be used to measure how well Anatara Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Anatara Lifesciences' Total Current Liabilities is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 163.6 K in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1.4 M in 2025. Common Stock Shares Outstanding is likely to gain to about 181.1 M in 2025, whereas Net Loss is likely to drop (1.9 M) in 2025.

Anatara Lifesciences Workforce Comparison

Anatara Lifesciences Benchmark Summation

Anatara Lifesciences Notable Stakeholders

The success or failure of an entity such as Anatara Lifesciences often depends on how effective the management is. Anatara Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Anatara management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Anatara management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Anatara Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Anatara Lifesciences. Check Anatara Lifesciences' Beneish M Score to see the likelihood of Anatara Lifesciences' management manipulating its earnings.

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.